Phibro Animal Health (NASDAQ:PAHC) updated its FY20 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.08 -1.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.66. The company issued revenue guidance of $833 -863 million, compared to the consensus revenue estimate of $857.96 million.
Several brokerages recently issued reports on PAHC. ValuEngine upgraded shares of Phibro Animal Health from a sell rating to a hold rating in a research note on Thursday, May 23rd. Zacks Investment Research upgraded shares of Phibro Animal Health from a sell rating to a hold rating in a research note on Monday, April 29th. Barclays began coverage on shares of Phibro Animal Health in a research note on Tuesday, June 11th. They issued an underweight rating and a $25.00 price target for the company. Gabelli upgraded shares of Phibro Animal Health from a hold rating to a buy rating and set a $42.00 price target for the company in a research note on Wednesday, May 8th. They noted that the move was a valuation call. Finally, Guggenheim began coverage on shares of Phibro Animal Health in a research note on Thursday, May 23rd. They issued a neutral rating for the company. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. Phibro Animal Health presently has a consensus rating of Hold and an average price target of $41.50.
Shares of Phibro Animal Health stock traded down $0.19 during trading on Tuesday, hitting $31.57. The company’s stock had a trading volume of 169,395 shares, compared to its average volume of 161,541. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41. The company has a fifty day simple moving average of $30.60 and a two-hundred day simple moving average of $30.99. The company has a market capitalization of $1.25 billion, a PE ratio of 18.14, a P/E/G ratio of 4.33 and a beta of 0.69. Phibro Animal Health has a 52 week low of $27.32 and a 52 week high of $50.40.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.52%. Phibro Animal Health’s payout ratio is 27.59%.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Recommended Story: What is a price target?
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.